Angelika Lásiková

Dr. Angelika Lásiková


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2022 in Marine Drugs
Verified
Journal Article
Open access
PDF file
MŠMária Štiblariková
Mária Štiblariková
ALAngelika Lásiková
Angelika Lásiková
TGTibor Gracza
Tibor Gracza
Marine microorganisms are an important source of natural polyketides, which have become a significant reservoir of lead structures for drug design due to their diverse biological activities. In this review, we provide a summary of the resources, structures, biological activities, and proposed biosynthetic pathways of the benzyl alcohol/salicylaldehyde-type polyketides. In addition, the total syntheses of these secondary metabolites from their discoveries to the present day are presented. This review could be helpful for researchers in the total synthesis of complex natural products and the use of polyketide bioactive molecules for pharmacological purposes and applications in medicinal chemistry.

28 February 2019 in Molecules
Verified
Journal Article
Open access
PDF file
ALAngelika Lásiková
Angelika Lásiková
JDJana Dohanosova
Jana Dohanosova
MŠMária Štiblariková
Mária Štiblariková
MPMartin Parák
Martin Parák
JMJan Moncol
Jan Moncol
TGTibor Gracza
Tibor Gracza
The paper describes the first total synthesis of natural varioxiranol A by chiral pool approach and confirmation of its absolute configuration by single-crystal X-ray analysis. The target varioxiranol A and its 4-epimer were obtained after 10 steps from single and available chiral source 1,2-O-isopropylidene-d-glyceraldehyde in an overall yield of 10% and 6%, respectively. A synthetic strategy based on the Julia–Kocieński coupling reaction between aromatic sulfone and corresponding aldose derivative makes it possible to prepare other interesting polyketide derivatives (varioxiranols B-G, varioxirane, varioxiranediols).

8 October 2024 in Molbank
Verified
Journal Article
Open access
PDF file
ALAngelika Lásiková
Angelika Lásiková
DVDaniel Vegh
Daniel Vegh
The synthesis of 4-(1H-tetrazol-5-yl)-2-(p-tolyl)quinoline 4 as a possible modification of the biphenyltetrazole substructure of losartan 1 is described. The transformation of 2-(p-tolyl)quinoline-4-carbonitrile 3 to the corresponding tetrazole 4 was carried out by the reaction of trimethysilyl azide and dibutyltin oxide as a catalyst in refluxing toluene. The title compound (4) was characterized by IR, 1H NMR, 13C NMR, and HRMS.